D. Medical Industries Ltd. rose the
most in a month after the maker of drug-delivery devices
received a U.S. patent for technology that combines a continuous
glucose monitor and insulin pump in the same product.
The shares jumped 5.8 percent, the most since Oct. 27, to
6.949 shekels at 11:10 a.m. in Tel Aviv, giving the Ramat Gan,
Israel-based company a market value of 54.9 million shekels
To contact the reporter on this story:
Susan Lerner in Jerusalem at
To contact the editor responsible for this story:
Claudia Maedler at
Press spacebar to pause and continue. Press esc to stop.